Navigation Links
Bacterin International Holdings, Inc. Receives Approval for Listing on NYSE Amex
Date:3/4/2011

such as "continue," "efforts," "expects," "anticipates," "intends," "plans," "believes," "estimates," "projects," "forecasts," "strategy," "will," "goal," "target," "prospects," "potential," "optimistic," "confident," "likely," "probable" or similar expressions or the negative thereof. These forward-looking statements are based on current expectations or beliefs and include, but are not limited to, statements about the Company's earnings and its expectations for the future due to among other things, the anticipated efforts of its sales force. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the Company's ability to meet its obligations under existing and anticipated contractual obligations; the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability and willingness of third-party manufacturers to timely and cost-effectively fulfill orders from the Company; the ability of the Company's customers to pay and the timeliness of such payments, particularly during recessionary periods; the Company's ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.


'/>"/>
SOURCE Bacterin International Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bacterin International Announces Major Orthopedic Hospital Group to Begin Use of OsteoSponge®SC
2. Bacterin International to Announce Launch of OsteoSponge®SC at American Academy of Orthopedic Surgeons 2011 Annual Meeting February 15-19
3. Bacterin International Holdings to Present at the OneMedForum San Francisco 2011
4. Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results
5. Bacterin International Holdings, Inc. Schedules Conference Call to Present Third Quarter 2010 Financial Results
6. Bacterin International to Present at Singular Research 5th Annual Best of the Uncovereds Conference
7. Bacterin International Holdings, Inc. to Present at the 6th Annual Fall Growth Stock Conference Hosted by Security Research Associates, Inc.
8. Bacterin International Holdings, Inc. Completes Merger and $7.5 Million Raise
9. Bacterin International Secures Three-Year Agreement to Distribute Biologic Products to Broadlanes Network of Over 6,000 Medical Facilities
10. Bacterin International Introduces OsteoSelect(R) DBM Putty
11. Bacterin International Completes $3 Million Private Placement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... ROSEMONT, Ill. , Aug. 3, 2015 ... ankle problem, and you,re looking for the best possible ... for the best outcome too, and now there,s a ... there. Following steps recommended by the American Orthopaedic ... after surgery can help you avoid complications and heal ...
(Date:8/3/2015)... FRANCISCO , Aug. 3, 2015  Sage Analytics ... of portable laboratory-quality cannabis potency measurement systems, announced its ... Bay Area Cruise Fundraiser. A limited number of tickets ... festivities and help a great cause while enjoying an ... scenic cruise around the San Francisco Bay at sunset. ...
(Date:8/3/2015)... FRANCISCO , August 3, 2015 ... size is expected to reach USD 24.7 billion ... Grand View Research Inc. Growing prevalence of neurological ... physiotherapy equipments market over the forecast period. The ... ultrasound and cryotherapy, advancement in the technologies coupled ...
Breaking Medicine Technology:Patient Guide: How to Prepare for Surgery 2Sage Analytics Sponsors California Cannabis Industry Association Bay Area Cruise FUNdraiser 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 2Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 3Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 4Physiotherapy Equipments Market Worth $24.7 Billion By 2022: Grand View Research, Inc. 5
... Echo Therapeutics, Inc. (OTC Bulletin Board: ... System as a non-invasive, wireless, transdermal continuous glucose monitoring ... delivery, today announced that it has raised approximately $2.5 ... Company,s stock and warrants, and it has received a ...
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today announced ... officer, is scheduled to present a company overview at the ... January 13th at 11:30 a.m. PST. (Logo:   ... or the subsequent archived recording, log on to www.rigel.com ...
Cached Medicine Technology:Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million 2Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million 3Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million 4
(Date:8/3/2015)... Ore. (PRWEB) , ... August 03, 2015 , ... They ... Providence St. Vincent Medical Center offers some of the best care in ... M.D., neurosurgeon and neurointerventionalist, achieved the fastest average blood clot removal time in the ...
(Date:8/3/2015)... , ... August 03, 2015 , ... ... of Appeals ruled in favor of the firm’s client Rebecca Hamsher, deciding that ... Medical Center must reimburse benefits for Hamsher’s residential treatment for bulimia, depression and ...
(Date:8/3/2015)... PA (PRWEB) , ... August 03, 2015 , ... ... Africa , Infectious diseases researchers from the University of Pittsburgh School of Medicine ... rollout of HIV prevention drugs in sub-Saharan Africa. , A cooperative agreement ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Seattle-based Genelex to offer pharmacogenetic lab testing and precision medicine solutions that can ... costs. , Annually, more than 8.6 million adverse drug events are reported ...
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent Pharma Solutions, the ... and consumer health products, today welcomed the announcement by OPKO Health that the ... for a new treatment for chronic kidney disease (CKD) and vitamin D insufficiency, ...
Breaking Medicine News(10 mins):Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3
... Inc.,(Nasdaq: ATRC ), a medical device company ... announced that its minimally invasive platform was,highlighted during ... techniques. On June 18, Dr. Kenneth,Ellenbogen, Vice Chairman ... Pacing at the Medical College of Virginia, chaired ...
... on MRIs with limited side effects, study found , , FRIDAY, ... to treat the "relapse-remitting" form of multiple sclerosis has been ... , Although the drug, laquinimod, is still experimental, having a ... patients. , "By and large, this doesn,t look as strong ...
... PRGO ; TASE) today announced that it ... Drug Administration to manufacture and market,Cetirizine Hydrochloride Syrup ... Consumer Healthcare,s Zyrtec(R) Syrup, 1mg/mL, indicated for the,relief ... Perrigo,s Chairman and CEO Joseph C. Papa stated, ...
... no added benefit , , THURSDAY, June 19 (HealthDay News) ... risk of HIV-1 infection in people who have sex ... finds. , Previous research has shown that herpes simplex ... of genital herpes -- increases the risk for HIV-1 ...
... Bills Delay and Fix Competitive Bidding System for ... Pete Stark,(D-CA), chair of the House Ways & ... DMEPOS Competitive Acquisition Reform,Act of 2008. Sens. Max ... member of the Senate Finance Committee, have introduced ...
... The results of a major international clinical trial coordinated ... the New England Journal of Medicine . The ... a prospective, multicentre project involving patients with heart failure ... of death in the population and associated atrial fibrillation ...
Cached Medicine News:Health News:The AtriCure Minimally Invasive Platform Highlighted by Prominent Cardiac Surgeons and Electrophysiologists at Cardiostim in Nice, France 2Health News:The AtriCure Minimally Invasive Platform Highlighted by Prominent Cardiac Surgeons and Electrophysiologists at Cardiostim in Nice, France 3Health News:The AtriCure Minimally Invasive Platform Highlighted by Prominent Cardiac Surgeons and Electrophysiologists at Cardiostim in Nice, France 4Health News:Experimental Drug Fights Multiple Sclerosis Activity 2Health News:Experimental Drug Fights Multiple Sclerosis Activity 3Health News:Perrigo Announces Approval for Rx Cetirizine Syrup 2Health News:Herpes Suppression May Not Prevent HIV Infection 2Health News:NCPA Statement Endorsing H.R. 6252 and S.3144 2Health News:The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation 2Health News:The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation 3
Swedish Knee Cage -- hinged to track knee motion. Effective control of genu recurvatum (back knee or knee hyperextension). Fits left or right....
... The Infrapatellar Band uses an ... the patellar tendon helping to ... and patella tendonitis. Focusing the ... tibial tubercle with less constriction ...
Designed to provide continuous cold therapy to the shoulder and back. Helps to reduce pain and swelling and speed rehab....
... immobilization following shoulder fusion, dislocation, reconstruction ... allows the shoulder to be positioned ... Following brachial plexus injury this orthosis ... stretch during the healing process and ...
Medicine Products: